In another study, it was explored in vitro and in pre-clinical models that miR-519d increases the sensitivity to cisplatin by targeting MCL-1 (Myeloid cell leukemia 1)—an important anti-apoptotic protein in cancer—in BC stem cells [102]. This evidence concerns the gene MCL1 and breast cancer.